Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4917-4919

  Okuda, Jun ^a   Hayashi, Naoki ^a   Wakahara, Yuka ^a   Gotoh, Naomasa ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENOXACIN; NORFLOXACIN; QUINOLONE; QUINOLONE DERIVATIVE; SPARFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DRUG SENSITIZATION; GENE EXPRESSION; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; VCA 0421 GENE; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; FLUOROQUINOLONES; QUINOLONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIBRIO CHOLERAE O1;

EID: 78049264362     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01652-09     Document Type: Article

References (14)

1. Adachi, T., M. Mizuuchi, E. Robinson, E. Appella, M. O'Dea, M. Gellert, and K. Mizuuchi. 1987. DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res. 15:771-783.
2. Baranwal, S., K. Dey, T. Ramamurthy, G. B. Nair, and M. Kundu. 2002. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob. Agents Chemother. 46:2676-2678.
3. Garg, P., S. Sinha, R. Chakraborty, S. K. Bhattacharya, G. B. Nair, T. Ramamurthy, and Y. Takeda. 2001. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob. Agents Chemother. 45:1605-1606.
4. Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
5. Nakamura, S. 1997. Mechanisms of quinolone resistance. J. Infect. Chemother. 3:128-138.
6. Nishibuchi, M., and J. B. Kaper. 1985. Nucleotide sequence of the thermostable direct hemolysin gene of Vibrio parahaemolyticus. J. Bacteriol. 162: 558-564.
7. Okuda, J., F. Murayama, E. Yamanoi, E. Iwamoto, S. Matsuoka, M. Nishibuchi, and T. Nakai. 2007. Base changes in the fliC gene of Edwardsiella tarda: possible effects on flagellation and motility. Dis. Aquat. Organ. 76: 113-121.
8. Okuda, J., and M. Nishibuchi. 1998. Manifestation of the Kanagawa phenomenon, the virulence-associated phenotype, of Vibrio parahaemolyticus depends on a particular single base change in the promoter of the thermostable direct haemolysin gene. Mol. Microbiol. 30:499-511.
9. Okuda, J., T. Ramamurthy, and S. Yamasaki. 2007. Antibacterial activity of ciprofloxacin against clinical strains of Vibrio cholerae O139 recently isolated from India. Yakugaku Zasshi 127:903-904.
10. Okuda, J., T. Ramamurthy, and S. Yamasaki. 2007. The potent antibacterial activity of sitafloxacin against fluoroquinolone-resistant clinical isolates of Vibrio cholerae O1. Microbiol. Immunol. 51:467-469. (Pubitemid 46641683)
11. Peng, H., and K. V. Marians. 1993. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J. Biol. Chem. 268:24481-24490.
12. Swanberg, S., and J. Wang. 1987. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J. Mol. Biol. 197:729-736.
13. Yamamoto, T., G. B. Nair, M. J. Albert, C. C. Parodi, and Y. Takeda. 1995. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob. Agents Chemother. 39:241-244.
14. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.